subscribeSubscribe
Merck defends antibiotic`s approval from 2019

Merck defends antibiotic`s approval from 2019
Zachary Brennan ENDPTS
17 May 2023
Share Share
Enforcement Report - Week of February 22, 2023

Enforcement Report - Week of February 22, 2023
FDA
22 Feb 2023
Share Share
Merck is shutting the doors at a 300-person plant in PA

Merck is shutting the doors at a 300-person plant in PA
F. Kansteiner FIERCEPHARMA
25 Mar 2022
Share Share
Novel antibiotic Recarbrio has launched in the UK

Novel antibiotic Recarbrio has launched in the UK
PHARMATIMES
20 Nov 2020
Share Share
FDA Approves Merck’s (imipenem, cilastatin, and relebactam) for the Treatment

FDA Approves Merck’s (imipenem, cilastatin, and relebactam) for the Treatment
MERCK
05 Jun 2020
Share Share
Results of Ph 3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™

Results of Ph 3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™
BUSINESSWIRE
06 May 2020
Share Share
Results of Ph3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™

Results of Ph3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™
BUSINESSWIRE
05 May 2020
Share Share
EMA’s Meeting highlights from CHMP) recommended five medicines for approval

EMA’s Meeting highlights from CHMP) recommended five medicines for approval
EMA
14 Dec 2019
Share Share
Merck touts latest results for antibiotic Recarbrio

Merck touts latest results for antibiotic Recarbrio
E. Sagonowsky FIERCE PHARMA
03 Oct 2019
Share Share
Merck touts Phase III data for antibacterial Recarbrio

Merck touts Phase III data for antibacterial Recarbrio
Kathy Wong ENDPTS
30 Sep 2019
Share Share